Trial Details
COMPLETEDBasic Information
| Clinical ID | c3530 |
|---|---|
| Identifier | NCT01896583 |
| Trial Title | A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Diarrhea Predominant Irritable Bowel Syndrome |
| Interventions | DRUG: ASP7147|DRUG: Placebo |
Participant Information
| Sponsor | Seldar Pharma, Inc. |
|---|---|
| City | Phoenix |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2013-11 |
|---|---|
| Primary Completion Date | 2014-03 |
| Completion Date | 2014-07 |